Transcatheter valve-in-valve interventions after aortic root replacement: A systematic review.
TAVI
aortic root surgery
cardiac surgery
transcatheter
valve‐in‐valve
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
26 Mar 2024
26 Mar 2024
Historique:
revised:
08
03
2024
received:
11
01
2024
accepted:
19
03
2024
medline:
27
3
2024
pubmed:
27
3
2024
entrez:
27
3
2024
Statut:
aheadofprint
Résumé
Structural valve deterioration after aortic root replacement (ARR) surgery may be treated by transcatheter valve-in-valve (ViV-TAVI) intervention. However, several technical challenges and outcomes are not well described. The aim of the present review was to analyze the outcomes of ViV-TAVI in deteriorated ARR. This review included studies reporting any form of transcatheter valvular intervention in patients with a previous ARR. All forms of ARR were considered, as long as the entire root was replaced. Pubmed, ScienceDirect, SciELO, DOAJ, and Cochrane library databases were searched until September 2023. Overall, 86 patients were included from 31 articles that met our inclusion criteria out of 741 potentially eligible studies. In the entire population, the mean time from ARR to reintervention was 11.0 years (range: 0.33-22). The most frequently performed techniques/grafts for ARR was homograft (67.4%) and the main indication for intervention was aortic regurgitation (69.7%). Twenty-three articles reported no postoperative complications. Six (7.0%) patients required permanent pacemaker implantation (PPI) after the ViV-TAVI procedure, and 4 (4.7%) patients had a second ViV-TAVI implant. There were three device migrations (3.5%) and 1 stroke (1.2%). Patients with previous ARR present a high surgical risk. ViV-TAVI can be considered in selected patients, despite unique technical challenges that need to be carefully addressed according to the characteristics of the previous surgery and on computed tomography analysis.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Stamou SC, Williams ML, Gunn TM, Hagberg RC, Lobdell KW, Kouchoukos NT. Aortic root surgery in the United States: a report from the society of thoracic surgeons database. J Thorac Cardiovasc Surg. 2015;149(1):116‐122.
Wallen T, Habertheuer A, Bavaria JE, et al. Elective aortic root replacement in North America: analysis of STS adult cardiac surgery database. Ann Thorac Surg. 2019;107(5):1307‐1312.
Yamabe T, Pearsall CA, Zhao Y, et al. Incidence, cause, and outcome of reinterventions after aortic root replacement. Ann Thorac Surg. 2022;113(1):25‐32.
David TE, Feindel CM. An aortic valve‐sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg. 1992;103(4):617‐622.
Sarsam MAI, Yacoub M. Remodeling of the aortic valve anulus. J Thorac Cardiovasc Surg. 1993;105(3):435‐438.
Schneider AW, Putter H, Hazekamp MG, et al. Twenty‐year experience with stentless biological aortic valve and root replacement: informing patients of risks and benefits. Eur J Cardiothorac Surg. 2018;53(6):1272‐1278.
Brown JA, Serna‐Gallegos D, Kilic A, et al. Midterm outcomes of stented versus stentless bioprosthetic valves after aortic root replacement. Semin Thorac Cardiovasc Surg. 2022;34(4):1147‐1155.
Rodriguez‐Gabella T, Voisine P, Puri R, Pibarot P, Rodés‐Cabau J. Aortic bioprosthetic valve durability. J Am Coll Cardiol. 2017;70(8):1013‐1028.
Klotz S, Stock S, Sievers HH, et al. Survival and reoperation pattern after 20 years of experience with aortic valve‐sparing root replacement in patients with tricuspid and bicuspid valves. J Thorac Cardiovasc Surg. 2018;155(4):1403‐1411.
Borger MA, Prasongsukarn K, Armstrong S, Feindel CM, David TE. Stentless aortic valve reoperations: a surgical challenge. Ann Thorac Surg. 2007;84(3):737‐744.
Balsam LB, Grossi EA, Greenhouse DG, et al. Reoperative valve surgery in the elderly: predictors of risk and long‐term survival. Ann Thorac Surg. 2010;90(4):1195‐1201.
Cekmecelioglu D, Preventza O, Dougherty KG, et al. Transcatheter valve‐in‐valve implantation for degenerated stentless aortic bioroots. Ann Cardiothorac Surg. 2021;10(5):641‐650.
Brener MI, Yamabe T, Leb J, Khalique OK, Takayama H, George I. Feasibility of transcatheter aortic valve replacement in prior aortic root surgery: insights from virtual modeling. Circulation. 2020;13(11):e009539.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29:372:n71.
Moola S, Munn Z, Tufanaru C, et al. Chapter 7: Systematic Reviews of Etiology and Risk—JBI Manual for Evidence Synthesis. JBI Man Evid Synth. 2020: Available from https://synthesismanual.jbi.global
Sterne JA, Hernán MA, Reeves BC, et al. ROBINS‐I: a tool for assessing risk of bias in non‐randomised studies of interventions. BMJ. 2016;355:i4919.
Attia R, Bapat V. Transcatheter aortic valve implantation for treatment of failing homograft with preexisting mechanical mitral prosthesis. Catheter Cardiovasc Interv. 2013;82(2):324‐327.
Attia R, Visagan R, Nowell J, Chadalavada S, Thomas M, Bapat V. Transapical transcatheter aortic valve implantation in a complex aortic surgical patient: a case involving the youngest valve‐in‐valve implantation with a 29 mm transcather valve. Exp Clin Cardiol. 2012;17(4):251‐253.
Beigel R, Siegel RJ, Kahlon RS, Jilaihawi H, Cheng W, Makkar RR. Transcatheter aortic valve implantation for a failed bio‐bentall in patients with marfan syndrome. Cardiology. 2014;128(1):9‐12.
Chan PH, Di Mario C, Davies SW, Kelleher A, Trimlett R, Moat N. Transcatheter aortic valve implantation in degenerate failing aortic homograft root replacements. J Am Coll Cardiol. 2011;58(16):1729‐1730.
Chen M, Michel JM, Schmiady MO, et al. Transcatheter aortic Valve‐in‐Valve replacement for degenerated homograft and pseudoaneurysm of the mitral‐aortic intervalvular fibrosa. JACC Cardiovasc Interven. 2023;16(2):231‐234.
Dainese L, Fusari M, Trabattoni P, Biglioli P. Redo in aortic homograft replacement: transcatheter aortic valve as a valid alternative to surgical replacement. J Thorac Cardiovasc Surg. 2010;139(6):1656‐1657.
Díez JG, Schechter M, Dougherty KG, Preventza O, Coselli JS. Transcatheter aortic valve‐in‐valve replacement instead of a 4th sternotomy in a 21‐year‐old woman with aortic homograft failure. Tex Heart Inst J. 2016;43(4):334‐337.
Duncan A, Davies A, Quarto C, Davies S. Long‐term outcomes of valve‐in‐valve transcatheter aortic valve implantation for degenerate homograft aortic valve replacement. EuroIntervention. 2020;16(9):760.
Elghannam M, Haldenwang PL, Aljabery Y, Moustafine V, Strauch J. Open transcatheter aortic valve implantation on a degenerated bioprosthetic valve conduit. J Surg Case Rep. 2018;2018(9):rjy233.
Favero L, De Leo A, Daniotti A, et al. Transfemoral transcatheter aortic valve implantation for treatment of severe aortic regurgitation in a patient with previous aortic valve‐sparing operation according to David. Cardiovasc Revascular Med. 2017;18(8):611‐615.
Hollander K, Montealegre‐Gallegos M, Mahmood F. Valve‐in‐valve‐in homograft: a case of a repeat transcatheter aortic valve replacement in a patient with an aortic homograft. Ann Card Anaesth. 2016;19(4):737‐739.
Ihlberg L, Sahlman A, Sinisalo J, Rapola J, Laine M. Transaortic valve‐in‐valve implantation after previous aortic root homograft. Ann Thorac Surg. 2012;94(5):1718‐1721.
Itaya N, Sasaki K, Takaseya T, et al. Transcatheter aortic valve implantation for aortic valve stenosis 17 years after aortic root remodeling via the yacoub method. J Cardiol Cases. 2023;27(6):287‐289.
Joo HJ, Hong SJ, Yu CW. Transcatheter aortic valve‐in‐valve implantation for severe bioprosthetic stenosis after bentall operation using a homograft in a patient with behçet's disease. J Heart Valve Dis. 2015;24(2):217‐219.
Koren O, Patel V, Kaewkes D, et al. Transcatheter aortic valve replacement for bicuspid aortic insufficiency after valve‐sparing aortic root replacement. JACC Case Rep. 2021;3(17):1798‐1802.
Laricchia A, Mangieri A, Gallo F, et al. Valve‐in‐Valve transcatheter aortic valve implantation with acurate neo for a degenerated bio‐bentall. cardiovasc revascularization med. Mol Interv. 2020;21(11S):18‐20.
López‐Otero D, Teles R, Gómez‐Hospital JA, et al. Implante percutáneo de válvula aórtica: seguridad y eficacia del tratamiento del homoinjerto aórtico disfuncionante. Rev Esp Cardiol. 2012;65(4):350‐355.
Mihailovič PM, Žižek D, Vitez L, Holc P, Klokočovnik T, Bunc M. Case report: a complex case of valve‐in‐valve TAVI and left bundle branch pacing for severe aortic regurgitation with partially corrected type A aortic dissection and low ejection fraction. Front Cardiovasc Med. 2023;10:1206811.
Hong JC, Orozco‐Sevilla V, Diez JG, Coselli JS. Transcatheter aortic valve‐in‐valve‐in‐valve replacement in a young woman with transcatheter structural valve deterioration within a degenerated aortic root homograft. Tex Heart Inst J. 2023;50(2):e227874.
Olsen LK, Engstrøm T, Søndergaard L. Transcatheter valve‐in‐valve implantation due to severe aortic regurgitation in a degenerated aortic homograft. J Invas Cardiol. 2009;21(10):197‐200.
Putrino AL, Best M, Yong G. Improved quality of life two‐years post transcatheter aortic valve replacement for a regurgitant aortic homograft. Heart Lung Circ. 2015;24(4):e51‐e55.
Schmoeckel M, Boekstegers P, Nikolaou K, Reichart B. First successful transapical aortic valve implantation after aortic allograft replacement. J Thorac Cardiovasc Surg. 2009;138(4):1016‐1017.
Takei Y, Suzuki R, Shibasaki I, et al. Transcatheter aortic valve‐in‐surgical aortic valve for a patient with repeated healed endocarditis: a case report. Surg Case Rep. 2023;9(1):155.
Tay ELW, Kong WKF, Yip JWL, Low TT, Hon JKF. Successful transcatheter aortic valve replacement for severe aortic valve regurgitation following a David I valve‐sparing procedure. JACC Cardiovasc Interven. 2017;10(11):e101‐e103.
Teixeira P, Ferreira W, Pires‐Morais G, Rodrigues A, Braga P. Valve‐in‐valve transcatheter aortic valve implantation using fluoroscopic guidance for late failure of the bioprosthetic bentall conduit BioValsalva™ vascutek. Cureus. 2020;12(12):12006.
Tugulan CI, Bedi R, Jacks D, Parrino EP, Spindel SM. Transcatheter aortic valve replacement after valve‐sparing aortic root surgery. J Card Surg. 2021;36(6):2117‐2120.
Unzué L, García E, Díaz‐Antón B, Teijeiro‐Mestre R, Río MR, del Pinto ÁG. Transfemoral TAVI with balloon‐expandable valve for failing aortic root homografts. REC Interv Cardiol Engl Ed. 2022;4(2):145‐147.
Varotto L, Spigolon L, Dotto A, et al. Case report: severe aortic valve regurgitation and pseudoaneurysm in aortic Valve‐Sparing operation: the usefulness of multimodality imaging in a complex clinical scenario. Front Cardiovasc Med. 2021;8:719405.
Perrin N, Corona S, Loobuyck V, et al. Transcatheter aortic valve replacement for failed valve sparing procedures. JACC Cardiovasc Interven. 2023;16(1):120‐122.
Otalvaro L, Alfonso CE, O'Neill WW, O'Neill BP, Heldman AW. Transfemoral aortic valve replacement in failing aortic root homografts. J Card Surg. 2014;29(3):333‐336.
Bentall H, De Bono A. A technique for complete replacement of the ascending aorta. Thorax. 1968;23(4):338‐339.
Yerokun BA, Vallabhajosyula P, Vekstein AM, et al. Long‐term outcomes of aortic root operations in the United States among medicare beneficiaries. J Thorac Cardiovasc Surg. 2023;165(2):554‐565.
Nappi F, Al‐Attar N, Spadaccio C, Chello M, Lusini M, Acar C. Aortic valve homograft: 10‐year experience. Surg Technol Int. 2014;24:265‐272.
Brown JA, Serna‐Gallegos D, Kilic A, et al. Outcomes of reoperative aortic root surgery. J Thorac Cardiovasc Surg. 2023;166(3):716‐724.
Esaki J, Leshnower BG, Binongo JN, et al. Reoperative aortic root replacement: outcome in a contemporary series. J Thorac Cardiovasc Surg. 2017;154(3):800‐808.
Joudinaud TM, Baron F, Raffoul R, et al. Redo aortic root surgery for failure of an aortic homograft is a major technical challenge. Eur J Cardiothorac Surg. 2008;33(6):989‐994.
Englum BR, Pavlisko EN, Mack MC, et al. Pseudoaneurysm formation after medtronic freestyle porcine aortic bioprosthesis implantation: a word of caution. Ann Thorac Surg. 2014;98(6):2061‐2067.
Tarantini G, Sathananthan J, Fabris T, et al. Transcatheter aortic valve replacement in failed transcatheter bioprosthetic valves. JACC Cardiovasc Interven. 2022;15(18):1777‐1793.
Ribeiro HB, Rodés‐Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J. 2018;39(8):687‐695.
Gotzmann M, Mügge A, Bojara W. Transcatheter aortic valve implantation for treatment of patients with degenerated aortic bioprostheses‐‐valve‐in‐valve technique. Catheter Cardiovasc Interv. 2010;76(7):1000‐1006.
Webb JG, Wood DA, Ye J, et al. Transcatheter valve‐in‐valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121(16):1848‐1857.
Dvir D, Leipsic J, Blanke P, et al. Coronary obstruction in transcatheter aortic valve‐in‐valve implantation: preprocedural evaluation, device selection, protection, and treatment. Circulation. 2015;8(1):e002079.
Yamamoto M, Shimura T, Kano S, et al. Impact of preparatory coronary protection in patients at high anatomical risk of acute coronary obstruction during transcatheter aortic valve implantation. Int J Cardiol. 2016;217:58‐63.
Khan JM, Dvir D, Greenbaum AB, et al. Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement. JACC Cardiovasc Interven. 2018;11(7):677‐689.
Dvir D, Leon MB, Abdel‐Wahab M, et al. First‐in‐human dedicated leaflet splitting device for prevention of coronary obstruction in transcatheter aortic valve replacement. JACC Cardiovasc Interven. 2023;16(1):94‐102.